


Market Size, Share Global Outlook and Forecast 2025-2032 Publication Date: April 9, 2025
The global antiserum market refers to the segment of the biopharmaceutical industry involved in the production, distribution, and application of antiserum.
Antiserum is a bloodderived product that contains polyclonal antibodies and is primarily used for passive immunization against toxins, pathogens, and venom
Derived from human or animal sources (typically equines or sheep), antisera play a vital role in neutralizing antigens such as viruses, bacteria, and venomous agents.
Ethical concerns around animal-derived products may affect acceptance and encourage stricter regulations.
• Global Market Value (2024): US$ 2.1 Billion
• Projected Market Value (2032): US$ 2.7 Billion
• CAGR (2025-2031): 3.7%
Rising Demand for Immunoglobulin Therapy
Prevalence of Snakebites in Developing Regions
By Type
By Application
Monovalent Antiserum
Polyvalent Antiserum
By Region
Infectious Disease Prevention
Toxin Neutralization
Others
North America
Europe
Middle East & Africa
Leading due to robust healthcare infrastructure, high expenditure on biologics, and active R&D.
Strong demand supported by advanced biotechnological capabilities and favorable government policies.
Fastest growing due to high incidence of snakebites, rabies, and other infectious diseases.
Follow
LinkedIn: https://www.linkedin.com/company/24 chemicalresearchold/posts/ Facebook: https://www.facebook.com/24chemicalr esearch/ Twitter: https://x.com/24Chemical